Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 9 articles: HTML format

Single Articles

September 2022
1. LACROIX M, Beauchemin H, Fraszczak J, Ross J, et al
   The X-Linked Helicase DDX3X Is Required for Lymphoid Differentiation and MYC-Driven Lymphomagenesis.
   Cancer Res. 2022;82:3172-3186.
   PubMed     Abstract available
   
   
   January 2022
2. DEVIN J, Caneque T, Lin YL, Mondoulet L, et al
   Targeting cellular iron homeostasis with ironomycin in diffuse large B cell lymphoma.
   Cancer Res. 2022 Jan 25. pii: 0008-5472.CAN-21-0218.
   PubMed     Abstract available
   
   
   December 2021
3. SZYDLOWSKI M, Garbicz F, Jablonska E, Gorniak P, et al
   Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies.
   Cancer Res. 2021;81:6029-6043.
   PubMed     Abstract available
   
   
   November 2021
4. DHURI K, Gaddam RR, Vikram A, Slack FJ, et al
   Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
   Cancer Res. 2021;81:5613-5624.
   PubMed     Abstract available
   
   
   October 2021
5. CALVO-VIDAL MN, Zamponi N, Krumsiek J, Stockslager MA, et al
   Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas.
   Cancer Res. 2021;81:5202-5216.
   PubMed     Abstract available
   
   
   September 2021
6. SOSHNEV AA, Allis CD, Cesarman E, Melnick AM, et al
   Histone H1 mutations in lymphoma: a link(er) between chromatin organization, developmental reprogramming, and cancer.
   Cancer Res. 2021 Sep 27. pii: 0008-5472.CAN-21-2619.
   PubMed     Abstract available
   
   
   June 2021
7. SPASEVSKA I, Myklebust JH
   What It Takes to Transform a T Cell.
   Cancer Res. 2021;81:3160-3161.
   PubMed     Abstract available
   
   
   
8. PAWLICKI JM, Cookmeyer DL, Maseda D, Everett JK, et al
   NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation.
   Cancer Res. 2021;81:3241-3254.
   PubMed     Abstract available
   
   
   May 2021
9. LEE CL, Brock KD, Hasapis S, Zhang D, et al
   Whole exome sequencing of radiation-induced thymic lymphoma in mouse models identifies Notch1 activation as a driver of p53 wild-type lymphoma.
   Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-2823.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: